Loomis, Sayles & Company
CME icon

Loomis, Sayles & Company’s CME Group CME Stock Holding History

Loomis, Sayles & Company’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.02M Sell
13,686
-691
-5% -$191K ﹤0.01% 466
2026
Q1 		$4.25M Sell
14,377
-10,292
-42% -$3.06M 0.01% 427
2025
Q4 		$6.74M Sell
24,669
-3,680
-13% -$1,000K 0.01% 402
2025
Q3 		$7.66M Sell
28,349
-492
-2% -$134K 0.01% 395
2025
Q2 		$7.95M Buy
28,841
+28,155
+4,104% +$7.66M 0.01% 400
2025
Q1 		$182K Buy
686
+293
+75% +$72.3K ﹤0.01% 533
2024
Q4 		$91K Sell
393
-91
-19% -$20.9K ﹤0.01% 569
2024
Q3 		$107K Buy
484
+39
+9% +$8.07K ﹤0.01% 541
2024
Q2 		$87K Buy
445
+23
+5% +$4.75K ﹤0.01% 559
2024
Q1 		$91K Sell
422
-64
-13% -$13.4K ﹤0.01% 554
2023
Q4 		$102K Buy
486
+46
+10% +$9.81K ﹤0.01% 531
2023
Q3 		$88K Buy
440
+37
+9% +$7.36K ﹤0.01% 538
2023
Q2 		$75K Sell
403
-139
-26% -$25.7K ﹤0.01% 560
2023
Q1 		$104K Buy
542
+106
+24% +$19.2K ﹤0.01% 535
2022
Q4 		$73K Sell
436
-50
-10% -$8.69K ﹤0.01% 569
2022
Q3 		$86K Buy
+486
New +$96K ﹤0.01% 530
2022
Q2 		– Sell
-9
Closed -$2K – 987
2022
Q1 		$2K Buy
+9
New +$2.11K ﹤0.01% 929
2020
Q3 		– Sell
-4,561
Closed -$741K – 668
2020
Q2 		$741K Buy
4,561
+4,418
+3,090% +$792K ﹤0.01% 473
2020
Q1 		$25K Sell
143
-215
-60% -$42.8K ﹤0.01% 571
2019
Q4 		$72K Sell
358
-150
-30% -$30.8K ﹤0.01% 649
2019
Q3 		$107K Buy
+508
New +$106K ﹤0.01% 550
2016
Q1 		– Sell
-8,654
Closed -$784K – 1066
2015
Q4 		$784K Hold
8,654
– – ﹤0.01% 599
2015
Q3 		$803K Buy
+8,654
New +$823K ﹤0.01% 570

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Loomis, Sayles & Company's CME Position: Q2 2026 in Review

Loomis, Sayles & Company reduced its CME Group (CME) stake by 4.8% in Q2 2026, selling an estimated $191K and leaving 13,686 shares worth $3.02M. The position accounts for ﹤0.01% of the portfolio, ranked #466.

Loomis, Sayles & Company first reported a position in CME in Q3 2015 and has held it in 23 quarters since. The position peaked at $7.95M in Q2 2025. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Loomis, Sayles & Company held 13,686 shares of CME Group worth $3.02M as of Q2 2026.
  • Loomis, Sayles & Company sold 691 CME Group shares in Q2 2026, an estimated $191K.
  • CME Group made up ﹤0.01% of Loomis, Sayles & Company's portfolio in Q2 2026, its #466 holding.
  • Loomis, Sayles & Company first reported a position in CME Group in Q3 2015 and has held it in 23 quarters since.
  • Loomis, Sayles & Company's CME Group position peaked at $7.95M in Q2 2025.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.